Page last updated: 2024-08-25

almagate and Genetic Predisposition

almagate has been researched along with Genetic Predisposition in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kurz-Levin, M; Michels, S	1
Behar-Cohen, F; Berdugo, M; Sennlaub, F	1

Reviews

1 review(s) available for almagate and Genetic Predisposition

Article	Year
[Age-related macular degeneration (AMD)]. Therapeutische Umschau. Revue therapeutique, 2009, Volume: 66, Issue:3 Topics: Adult; Age Factors; Aged; Antioxidants; Aptamers, Nucleotide; Diet; Fluorescein Angiography; Fundus Oculi; Genetic Predisposition to Disease; Humans; Macular Degeneration; Middle Aged; Photochemotherapy; Polymorphism, Genetic; Prevalence; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Zinc	2009

Article

Year

Therapeutische Umschau. Revue therapeutique, 2009, Volume: 66, Issue:3

Topics: Adult; Age Factors; Aged; Antioxidants; Aptamers, Nucleotide; Diet; Fluorescein Angiography; Fundus Oculi; Genetic Predisposition to Disease; Humans; Macular Degeneration; Middle Aged; Photochemotherapy; Polymorphism, Genetic; Prevalence; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Tomography, Optical Coherence; Vascular Endothelial Growth Factor A; Visual Acuity; Zinc

2009

Other Studies

1 other study(ies) available for almagate and Genetic Predisposition

Article	Year
[Age-related macular degeneration: therapeutic hopes]. Medecine sciences : M/S, 2007, Volume: 23, Issue:2 Topics: Age of Onset; Aged; Aged, 80 and over; Aging; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Double-Blind Method; Female; Genetic Predisposition to Disease; Humans; Macular Degeneration; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Ranibizumab; Vascular Endothelial Growth Factor A	2007

Article

Year

Medecine sciences : M/S, 2007, Volume: 23, Issue:2

Topics: Age of Onset; Aged; Aged, 80 and over; Aging; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Double-Blind Method; Female; Genetic Predisposition to Disease; Humans; Macular Degeneration; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Ranibizumab; Vascular Endothelial Growth Factor A

2007